CI

CI

USD

The Cigna Group Common Stock

$264.660+6.960 (2.701%)

Precio en Tiempo Real

Healthcare
Healthcare Plans
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$257.700

Máximo

$264.800

Mínimo

$256.000

Volumen

3.20M

Fundamentos de la Empresa

Capitalización de Mercado

70.7B

Industria

Healthcare Plans

País

United States

Estadísticas de Negociación

Volumen Promedio

1.74M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $239.51Actual $264.660Máximo $350

Informe de Análisis de IA

Última actualización: 3 nov 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

Cigna (CI) Stock Analysis: Finding Opportunity in Recent Turmoil

What Happened to Cigna's Stock?

Cigna took a serious hit recently. On October 30th, shares plunged 18% to $247.10 on massive volume - nearly 5.5 times their average trading activity. The selling continued the next day, dropping the stock to $244.41. This puts CI dangerously close to its 52-week low of $240.67.

What's puzzling is this crash happened despite generally positive news. The company beat Q3 earnings estimates, Goldman Sachs just initiated coverage with a strong Buy rating and $370 price target (that's 50% above current levels), and they announced meaningful initiatives to reduce medication costs for Americans.

Reading Between the Price Lines

Let's unpack what's really happening with Cigna's chart:

  • The Setup: Through most of August and September, CI built a solid upward trend, climbing from $260 to over $310
  • The Breakdown: After peaking near $315, the stock drifted lower through October
  • The Crash: That October 30th drop was no ordinary correction - it was a full-blown panic sell-off

Here's what stands out: the volume spike on October 30th wasn't normal distribution. When volume jumps that high during a sharp decline, it usually means big institutional players are exiting positions all at once. The good news? The selling pressure appears exhausted - the follow-through day on October 31st showed much weaker volume.

Why This Might Be Your Entry Window

Three compelling reasons suggest the worst may be over:

  1. Technical Signals Flashing Green: The stock now sits right at its support level ($244.33). When prices bounce off support with conviction, it often marks a turning point. Right now, the distance between current price and support is practically nonexistent - meaning we're at the make-or-break point.

  2. Goldman's Confidence: Their $370 price target isn't some random number. At current levels, that represents serious upside potential. What's interesting is they're not alone - 24 analysts maintain strong buy ratings.

  3. The News/Price Disconnect: Positive earnings, strategic initiatives, and dividend stability shouldn't result in an 18% single-day drop. This mismatch creates what traders call "mispricing" - a temporary gap between actual value and market price

Noticias Relacionadas

Analyst Upgrades

Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market

Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.

Ver más
Analysts Lower Cigna Targets As PBM Segment Guidance Surprises Market
Analyst Upgrades

TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333

TD Cowen analyst Charles Rhyee maintains Cigna Group with a Buy and lowers the price target from $387 to $333.

Ver más
TD Cowen Maintains Buy on Cigna Group, Lowers Price Target to $333
Analyst Upgrades

Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330

Goldman Sachs analyst Scott Fidel maintains Cigna Group with a Buy and lowers the price target from $370 to $330.

Ver más
Goldman Sachs Maintains Buy on Cigna Group, Lowers Price Target to $330
Analyst Upgrades

JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375

JP Morgan analyst Lisa Gill maintains Cigna Group with a Overweight and lowers the price target from $428 to $375.

Ver más
JP Morgan Maintains Overweight on Cigna Group, Lowers Price Target to $375
Analyst Upgrades

Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300

Barclays analyst Andrew Mok maintains Cigna Group with a Overweight and lowers the price target from $383 to $300.

Ver más
Barclays Maintains Overweight on Cigna Group, Lowers Price Target to $300
Reuters

Health insurer Cigna beats quarterly profit estimates on health services strength

Cigna Group beat Wall Street estimates for third-quarter profit on Thursday, driven by strength in the company's health services unit Evernorth that houses its pharmacy benefit management business.

PR Newswire

Evernorth Announces New Era of Pharmacy Benefit Services to Lower Americans' Medication Costs

Evernorth, the health services division of The Cigna Group (NYSE:CI) today announced a new rebate-free pharmacy benefit model designed to help...

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 5 nov 2025, 05:51

BajistaNeutralAlcista

68.6% Confianza

Riesgo y Negociación

Nivel de Riesgo1/5
Riesgo Bajo
Adecuado Para
ConservadorValor
Guía de Negociación

Punto de Entrada

$244.87

Toma de Ganancias

$249.29

Stop Loss

$219.96

Factores Clave

PDI 7.0 está por encima de MDI 6.9 con ADX 11.9, lo que sugiere una tendencia alcista
El volumen de operaciones es 12.7 veces el promedio (20,150), lo que indica una presión de compra extremadamente fuerte
El MACD 0.2199 está por encima de la línea de señal 0.2029, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.